Page 7 - தனபெ பார்மா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mitsubishi Tanabe Pharma America Presents Data on Impact of ALS Symptoms on Patients Ability to Independently Conduct Daily Activities Analysis Shared at 2021 Muscular Dystrophy Association Annual Clinical & Scientific Conference News provided by Share this article Share this article JERSEY CITY, N.J., March 17, 2021 /PRNewswire/  Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced findings from a new analysis evaluating the impact of symptom progression on the ability of people with amyotrophic lateral sclerosis (ALS) to independently conduct activities of daily living (ADLs). The findings were shared during a virtual presentation at the 2021 Muscular Dystrophy Association Clinical & Scientific Conference. As part of our commitment to patients and their caregivers, MTPA wanted to explore how different disease symptom progression impacts an ALS patients ability to independently perform daily activities, such as cleaning, housework, cooking and traveling outside

United statesGustavoa suarez zambranoDebbie etchisonTanabe pharmaMitsubishi tanabe pharma america incMitsubishi tanabe pharma corporationOverview of mitsubishi tanabe pharma corporationMitsubishi tanabe pharma holdings america incMuscular dystrophy association clinical scientific conferenceMitsubishi tanabe pharma americaDystrophy association clinicalVice presidentMedical affairsAbout mitsubishi tanabe pharma americaJersey cityMitsubishi tanabe pharma holdings america